4Midthun K,Grnenberg H B,Hoshino Y, et al.Reassortant rotaviruses as potential live rotavirus vaccine candidates[J].J Virol, 1985,53:949-954.
5Eglee Perez M, glass R, Alvarez G. Rhesus rotavirusbased quadrivalent vaccine is efficacious despite age,socioeconomic conditions and seasonality in Venezuela[J].Vaccine,2000,19(7-8):976-981.
6Clements Mann M L, Dudas R, Hoshino Y, et al. Safety and immunogenicity of live attenuated quadrivalent human-boving(UK) reassortant rotavirus vaccine administered with childhood vaccines to infants [J]. Vaccine,2001,19(32) :4676-4684.
7Naksgomi T. Intussusception and an oral rotavirus vaccine[J].N Engl J Med,2001,344(24): 1866-1867.
8Xu Z Z,krougliak V,Prevec L. Investigation of promtoter function in human and animal cells infected with human recomhinant adenovirus expressing rotaviru antigen Vp7sc[J] .J Gen Virol, 1995,76(Pt 8) :71-76.
9Crawford S E,Cohen J,Burroug M H.Characterization of viruslike paroles by the expression of rotavirus capsid proteins in insect[J]. Cells J Virol, 1994, 68: 5945-5952.
10Ciarlet M S, Crawford U, Barone C, et al. Subunit rotavirus vaccine administered parenterally to rabbit induces active protective immunity[J]. J Virol, 1998, 72:9223-9246.
